- Home
- IOVA vs AEVA Comparison
IOVA vs AEVA Comparison
Compare IOVA & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- AEVA
- Stock Information
- Founded
- IOVA 2007
- AEVA 2019
- Country
- IOVA United States
- AEVA United States
- Employees
- IOVA N/A
- AEVA N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- AEVA Auto Parts:O.E.M.
- Sector
- IOVA Health Care
- AEVA Consumer Discretionary
- Exchange
- IOVA Nasdaq
- AEVA Nasdaq
- Market Cap
- IOVA 975.1M
- AEVA 964.6M
- IPO Year
- IOVA N/A
- AEVA N/A
- Fundamental
- Price
- IOVA $1.83
- AEVA $14.02
- Analyst Decision
- IOVA Buy
- AEVA Strong Buy
- Analyst Count
- IOVA 11
- AEVA 5
- Target Price
- IOVA $10.80
- AEVA $20.80
- AVG Volume (30 Days)
- IOVA 14.8M
- AEVA 2.0M
- Earning Date
- IOVA 11-06-2025
- AEVA 11-05-2025
- Dividend Yield
- IOVA N/A
- AEVA N/A
- EPS Growth
- IOVA N/A
- AEVA N/A
- EPS
- IOVA N/A
- AEVA N/A
- Revenue
- IOVA $241,525,000.00
- AEVA $13,825,000.00
- Revenue This Year
- IOVA $68.14
- AEVA $108.44
- Revenue Next Year
- IOVA $56.64
- AEVA $103.49
- P/E Ratio
- IOVA N/A
- AEVA N/A
- Revenue Growth
- IOVA 636.99
- AEVA 111.39
- 52 Week Low
- IOVA $1.64
- AEVA $2.52
- 52 Week High
- IOVA $12.51
- AEVA $38.80
- Technical
- Relative Strength Index (RSI)
- IOVA 34.71
- AEVA 38.41
- Support Level
- IOVA $1.94
- AEVA $15.96
- Resistance Level
- IOVA $2.20
- AEVA $18.50
- Average True Range (ATR)
- IOVA 0.14
- AEVA 1.33
- MACD
- IOVA -0.04
- AEVA -0.30
- Stochastic Oscillator
- IOVA 3.31
- AEVA 0.39
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.